Sree Chitra Tirunal Institute develops an anti cancer anti-inflamatory drug conjugated to human serum Albumin

The Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST) has recently developed an anti cancer anti-inflamatory drug conjugated to the human serum Albumin. It is an intravenous delivery system, enabling 100 fold increase in drug bio-availability and is a mix of human serum albumin and a plant based drug. This combination is the ..

Topics: Albumin • Branches of biology • Extensively drug-resistant tuberculosis • Infectious diseases • Medical specialties • Polymerase chain reaction • Serum • Totally drug-resistant tuberculosis • Tuberculosis • Tuberculosis in India

National Anti-TB Drug Resistance Survey

In March, 2018, the Union Health Ministry has released the National Anti-TB Drug Resistance Survey report. The findings of the report include: India which is home to 2.8 million TB patients, the largest in the world of which over a quarter of patients in India could be resistant to one or more drugs that can ..

Topics: Antibiotic-resistant bacteria • Clinical medicine • Extensively drug-resistant tuberculosis • Health • Medicine • Multi-drug-resistant tuberculosis • Multiple drug resistance • Totally drug-resistant tuberculosis • Tuberculosis • Tuberculosis in India • XDR